Home » Health » EMA will provide more information about AstraZeneca

EMA will provide more information about AstraZeneca

Photo: ANP

The European medicines agency EMA is expected to release a new analysis of AstraZeneca’s corona vaccine this Friday. The EMA previously concluded that a combination of blood clots (thrombosis) and a low platelet count (thrombocytopenia) can be a very rare side effect of the vaccine. But overall, the benefits of the shot still far outweigh the drawbacks, the EMA said.

These disadvantages were mainly found in women under the age of 60. Following the advice of the Health Council of Friday, April 9, the cabinet decided to only offer the AstraZeneca vaccine to people born in 1960 or earlier. It is not possible to choose something else yourself.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.